Stifel Financial’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $8.89K | Sell |
|
|||||
|
2024
Q4 | $23.4K | Sell |
|
|||||
|
2024
Q3 | $84.3K | Sell |
|
|||||
|
2024
Q2 | $136K | Sell |
|
|||||
|
2024
Q1 | $321K | Sell |
|
|||||
|
2023
Q4 | $164K | Sell |
|
|||||
|
2023
Q3 | $136K | Sell |
|
|||||
|
2023
Q2 | $330K | Buy |
|
|||||
|
2023
Q1 | $298K | Sell |
|
|||||
|
2022
Q4 | $544K | Buy |
|
|||||
|
2022
Q3 | $956K | Sell |
|
|||||
|
2022
Q2 | $1.15M | Buy |
|
|||||
|
2022
Q1 | $1.75M | Buy |
|
|||||
|
2021
Q4 | $2.32M | Buy |
|
|||||
|
2021
Q3 | $1.52M | Buy |
|
|||||
|
2021
Q2 | $1.03M | Buy |
|
|||||
|
2021
Q1 | $717K | Buy |
|
|||||
|
2020
Q4 | $695K | Sell |
|
|||||
|
2020
Q3 | $318K | Buy |
|
|||||
|
2020
Q2 | $259K | Buy |
|